Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory ...

Cancer remains a leading cause of death globally, with lung cancer being particularly lethal. Despite advancements in diagnostics and therapies, the five-year survival rates for advanced tumors have ...

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the "Company", "Zefiro", or "ZEFI") today announced that it has engaged TÜV SÜD America ("TÜV SÜD"), a technical inspection association that tests, inspects, ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...

Plus Therapeutics' Q4 2024 earnings reveal progress with REYOBIQ nearing FDA approval & CNSide's 2025 launch. Key hires & funding bolster milestones.

Life coaching requires no mental health education, and it sometimes attracts former therapists who have lost their license to practice, reports ProPublica. Other states making news are New York, Iowa, ...